Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Agence Nationale de la Recherche
Grant: ANR-17-CE15-0013-03
HHS | National Institutes of Health
Grant: R01 AI109023
NIAID NIH HHS
Grant: T32 AI106711
National Institutes of Health
Grant: 1R01AI109023-01A1
Defining P. falciparum resistance to artemisinin-based combination therapies
French National Research Agency (ANR)
Grant: ANR-17-CE15-0013
Deciphering the mechanisms of action of two antimalarial redox-active drugs with gametocytocidal and transmission-blocking properties - from yeast to malarial parasites
Centre National de la Recherche Scientifique
FWCI
4.18
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals